Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Sequoia: Results of a randomized phase iii trial of zanubrutinib versus bendamustine plus rituximab (br) in patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

#2022
#Oncology Research and Treatment

PMU Authors
Richard Greil, Alan Cohen

All Authors
Richard Greil, T. Robak, K. Giannopoulos, W. Jurczak, M. Simkovic, M. Shadman, A. Osterborg, L. Laurenti, P. Walker, S. Opat, H. Chan, H. Ciepluch, M. Tani, M. Trneny, DM Brander, IW Flinn, S. Grosicki, E. Verner, JR Brown, BS Kahl, P. Ghia, J. Li, T. Tian, L. Zhou, C. Marimpietri, JC Paik, Alan Cohen, P. Hillmen, CS Tam

Journal association
Oncology Research and Treatment

Abstract

We are sorry. The full text is not available.